Staging and Practical Management of Diabetic Retinopathy - Top-Institutions - MDSpire

Staging and Practical Management of Diabetic Retinopathy

Approximately half of patients who have severe NPDR and nearly 75% of patients who have very severe NPDR will progress to PDR within 1 year.

  • By

  • STEVEN FERRUCCI, OD, FAAO

  • BRENDA YEH, OD, FAAO

  • March 2, 2026

  • 11 min

Share

Top Institutions in Optometry

Brief introduction explaining scope and methodology.

  • #1

    Wilmer Eye Institute, Johns Hopkins University
    Wilmer Eye Institute, Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Retina
    • Diabetes-related eye disease

  • #2

    Massachusetts Eye and Ear Infirmary, Harvard Medical School
    Massachusetts Eye and Ear Infirmary, Harvard Medical School

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Retina
    • Diabetic Eye Disease

  • #3

    Bascom Palmer Eye Institute, University of Miami
    Bascom Palmer Eye Institute, University of Miami

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Retina
    • Diabetic Retinopathy

  • #4

    Moorfields Eye Hospital
    Moorfields Eye Hospital

    London, N/A

    Key Differentiators

    • Ophthalmology
    • Retina
    • Diabetic Retinopathy

Original Source(s)

Staging and Practical Management of Diabetic Retinopathy

  • by STEVEN FERRUCCI, OD, FAAO, BRENDA YEH, OD, FAAO

  • March 2, 2026

Related Content

Diabetic Retinal Disease Rates Narrow by Diabetes Type

US claims data showed rising prevalence of diabetic retinal disease in type 1 and type 2 diabetes, while incidence declined in type 1 diabetes and moved closer to type 2 rates by 2022.

A gender-based investigation of risk factors for infectious complications after percutaneous nephrolithotomy for kidney stones: insight for personalized management

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.